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Abstract
Coxiella burnetii is a Gram-negative, obligate intracellular bacterium and the causative
agent of Q fever. Infections are usually acquired after inhalation of contaminated particles,
where C. burnetii infects its cellular target cells, alveolar macrophages. Respiratory patho-
gens encounter the C-type lectin surfactant protein D (SP-D) during the course of natural
infection. SP-D is a component of the innate immune response in the lungs and other muco-
sal surfaces. Many Gram-negative pulmonary pathogens interact with SP-D, which can
cause aggregation, bactericidal effects and aid in bacterial clearance. Here we show that
SP-D binds to C. burnetii in a calcium-dependent manner with no detectable bacterial
aggregation or bactericidal effects. Since SP-D interactions with bacteria often alter macro-
phage interactions, it was determined that SP-D treatment resulted in a significant decrease
in C. burnetii interactions to a mouse alveolar macrophage model cell line MH-S indicating
SP-D causes a significant decrease in phagocytosis. The ability of SP-D to modulate mac-
rophage activation by C. burnetii was tested and it was determined that SP-D does not alter
the correlates measured for macrophage activation. Taken together these studies support
those demonstrating limited activation of alveolar macrophages with C. burnetii and demon-
strate interactions with SP-D participate in reduction of phagocyte attachment and
phagocytosis.
Introduction
Coxiella burnetii is a Gram-negative zoonotic bacterial pathogen that is the etiologic agent of Q
Fever in humans and coxiellosis in animals [1]. Q fever is usually acquired after contact with
infected animals. While infection with C. burnetii often results in asymptomatic seroconver-
sion, Q Fever can also present as an acute febrile illness, which can either resolve or result in
chronic infection most often manifesting as endocarditis [2]. C. burnetii is subject to an phe-
nomenon that occurs in many Gram-negative bacteria, the transition from “smooth” to
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“rough” LPS, which occurs after serial passage in a non-immunocompetent host [3]. This tran-
sition can occur via the deletion of O-antigen or core carbohydrate biosynthesis genes. C. bur-
netii RSA439 a clonal isolate that serves as a model for this phenomenon contains a deletion of
a 26 kDa fragment of the genome, which renders it unable to produce O-antigen [4]. Smooth
variants, designated phase I are virulent during animal infection, whereas, rough variants des-
ignated phase II are attenuated in immunocompetent animal infection. However, both phase I
and phase II infect and multiply equally in a variety of cell types [5].
Infection by C. burnetii occurs via inhalation of aerosolized bacteria into the alveolar space
within the lungs where C. burnetii proceeds to infect and survive within a variety of target cells,
predominantly alveolar macrophages. Alveolar macrophages represent a unique lineage due to
environmental conditions within the alveolar space [6]. Recent studies conducted with isolated
alveolar macrophages from bronchial alveolar lavage have shown that virulent and avirulent
strains of C. burnetii are able to infect alveolar macrophages and stimulate the production of
TNF-α, IL-6, and IL-10 [7]. In addition to this alveolar macrophage study, studies using other
monocytes or lineage macrophages have demonstrated that infection with either virulent or
avirulent C. burnetii results in the production of TNF-α and IL-6 [5]. Therefore, C. burnetii
infection triggers an early robust pro-inflammatory response.
Pulmonary pathogens are exposed to many components of the innate immune system that
are usually involved in clearance of these invading organisms. For example, respiratory patho-
gens that reach the alveolar space encounter C-type lectins including surfactant proteins, often
modeled by surfactant protein D (SP-D) [8]. SP-D is a hydrophilic protein that has been
shown to be involved in both pulmonary surfactant homeostasis and the innate immune
response [9]. Structurally SP-D is a tetramer composed of homotrimeric subunits that interact
via their N-terminal domain, have a collagen-like domain and a C-terminal carbohydrate rec-
ognition domain (CRD) [10]. SP-D binds to various self and non-self ligands through its CRD
in a calcium-dependent manner and then interacts with immune cells through its collagen-like
domain to activate immune cells for clearance of the pathogen [10]. SP-D has been shown to
directly interact with a number of bacteria including Pseudomonas aeruginosa, Streptococcus
pneumoniae, Escherichia coli, andMycobacterium tuberculosis leading to a number of physio-
logically relevant processes associated with bacterial clearance including agglutination, phago-
cytosis, and growth inhibition [11–15]. It is probable that C. burnetii interacts with SP-D in the
lungs before invasion of alveolar macrophages, which may regulate these interactions. In this
study, we show that SP-D binds directly to C. burnetii but does not lead to aggregation or cause
cytotoxic affects. In addition, we show that the interaction between SP-D and C. burnetiimod-
ulates bacterial attachment and phagocytosis by alveolar macrophages, but that the level of
macrophage activation is not altered.
Materials and Methods
Bacteria and cell culture
C. burnetii RSA439 and RSA493 were grown in either axenic ACCM-2 media or L-929 mouse
fibroblasts (ATCC CCL-1) and genome equivalent were determined by real-time PCR, as pre-
viously described [16,17]. Briefly, DNA was purified from C. burnetii at indicated time points
using Roche High Pure PCR Template Prep Kit and then 2 uL of purified DNA was used in 20
uL real time PCR reactions using ABI Sybergreen master mix (Applied Biosystems by Life
Technologies, Foster City, CA, USA) and primers specific for com1 (CBU_1910). Prior to use,
the C. burnetii were centrifuged and washed once in PBS to remove residual ACCM-2 or SP
Buffer. Escherichia coli DH5α were grown in LB broth and quantified using OD600 or viable
counts. Prior to use, E. coli were washed once with PBS to remove residual LB. RSA493
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experiments were conducted under BSL3 containment according to Texas A&M University
Office of Biosafety standard operating procedures. The murine alveolar macrophage cell line
(MH-S) [18] were propagated in RPMI supplemented with 1X GlutaMAX (Gibco by Life Tech-
nologies, Foster City, CA, USA), 10% heat-inactivated fetal bovine serum, 18 mM sodium
bicarbonate, 10 mMHEPES, 25 mM glucose, and 0.05 mM 2-mercaptoethanol at 37 degrees in
5% CO2. For C. burnetii infections MH-S cells were seeded at 1 x 10
5 per mL and allowed to
adhere overnight.
SP-D binding, agglutination and antimicrobial assays
Binding to SP-D was determined using a previously described solution phase assay with some
modifications [19]. Briefly, ~1 x 108 C. burnetii or E. coli were incubated with 1mg/mL recom-
binant human SP-D (R&D Systems Inc, Minneapolis, MN, USA) in PBS + 5 mM CaCl2, PBS
+ 5 mM CaCl2 + 0.1 M galactose or PBS + 5 mM CaCl2 +10 mM EDTA overnight at 37°C. Bac-
teria were washed three times with PBS via centrifugation and resuspended in PBS + 10X sam-
ple buffer. Samples were briefly boiled and then subjected to 12.5% SDS-PAGE and transferred
onto nitrocelluloase membrane at 100 V for 1 hour. The membrane was blocked with 10%
powdered milk in PBS and then probed with polyclonal anti-SP-D (My BioSource, San Diego,
CA, USA), polyclonal anti-C. burnetii, or E. coli antibodies for 1 hour at 37°C. The membranes
were washed 3 times with TBS + 0.05% Tween 20 and probed with HRP- goat anti-rabbit sec-
ondary antibody (BioRad, Hercules, CA, USA). The protein bands were visualized using
chemiluminescence reagent (GE Healthcare Life Sciences, Pittsburgh, PA, USA).
Agglutination assays were performed by incubated ~1 x 108 C. burnetii or E. coli with 1mg/
mL SP-D in PBS + 5mM CaCl2 in a cuvette that remained stationary for the duration of the
assay. At selected time points the OD600 of the bacterial suspension was measured.
Growth inhibition assays were performed using 1 x 103 E. coli or 1 x 105 C. burnetii. E. coli
were treated with 10mg/mL SP-D for 1 hr at 37°C and then subjected to viability counts. C.
burnetii were treated with 10mg/mL SP-D for 12 hrs at 37°C. C. burnetii suspensions were
added ACCM-2 and incubated at 37°C in a microaerophilic incubator at 2.5% O2 and 5% CO2.
Every two days, 1 ml bacterial culture was removed and DNA was extracted and quantified via
real-time PCR as previously described [16].
Attachment and Phagocytosis assay
MH-S cells were seeded at 1 x 105 cells per ml onto glass cover slips in 24 well tissue culture
plates. MH-S cells were infected with CFSE-stained (Molecular Probes by Life Technologies,
Foster City, CA, USA) C. burnetii at MOI 100 and incubated at 37°C. At the indicated time
post infection, media was removed and MH-S cells were washed 3 times with RPMI. Coverslips
were then fixed with 2% para-formaldehyde and the nuclei were stained with Hoescht (Molec-
ular Probes by Life Technologies, Foster City, CA, USA). Infected MH-S cells were visualized
using a Nikon-A1 confocal microscope with 450 and 488 nm filters using the 60X oil immer-
sion objective. A minimum of 100 nuclei fromMH-S cells were counted and CFSE C. burnetii
were enumerated within those cells. The infectivity index was calculated as the number of
infected cells (bound and internalized C. burnetii) divided by the total number of counted cells,
multiplied by 100.
Cytokine production
MH-S cells were infected with C. burnetii at an MOI of 100 and at the indicated times post
infection, RNA was extracted fromMH-S cells using QiaShredder columns (Qiagen, Valencia,
CA, USA) followed by RNEasy kit (Qiagen, Valencia, CA, USA) treatment according to
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manufacturer’s protocol. Residual DNA was removed using DNA-free kit (Ambion, by Life
Technologies, Foster City, CA, USA). RNA was then quantified using a nanophotometer
(Implen Inc, Westlake Village, CA, USA) and 500 ng was applied to each reverse transcription
reaction using TaqMan Reverse Transcription kit (Applied Biosystems by Life Technologies,
Foster City, CA, USA). After reverse transcription, 2.5 uL was used for real-time PCR using
primers listed in Table 1. The fold change in expression for each gene was determined using
the 2-ΔCt method and murine gapdh as a reference [20]. Average gadph Ct values among all
samples did not deviate more than ± 1 Ct over the 3 independent experiments run with each
sample in triplicated to verify reproducibility of results and to comply with MIQE standards
[21]. Student t-tests were conducted to determine significance. Nitrite production in MH-S cul-
ture supernatant was determined using Griess reagents (Invitrogen by Life Technologies, Fos-
ter City, CA, USA) according to the manufacturer’s protocol.
Results
SP-D bindsC. burnetii in a calcium-dependent manner, but does not
cause aggregation or inhibition of growth
To determine if SP-D binds to C. burnetii, we used a solution phase assay. As shown in Fig 1,
SP-D bound to C. burnetii. The addition of EDTA, a calcium chelator, abolished the interaction
between C. burnetii and SP-D, which confirms that the binding was calcium dependent, a hall-
mark of most SP-D interactions (Fig 1). In addition, the interaction between SP-D and C. bur-
netii was inhibited in the presence of galactose, a monosaccharide with a high binding affinity
for SP-D (Fig 1) [22]. The ability of SP-D to aggregate C. burnetii was determined using a spec-
trophotometry assay. SP-D was able to aggregate E. coli in agreement with previous results,
however, SP-D was unable to aggregate C. burnetii (Fig 2a and 2b) [14]. To determine if SP-D
was bactericidal towards C. burnetii we incubated the bacteria with SP-D and the ability to rep-
licate was monitored in ACCM-2. SP-D did not significantly effect the viability of C. burnetii,
Table 1. Real-time polymerase chain reaction primers used in this study.
Primer Sequence
Il1b F GCA ACT GTT CCT GAA CTC AAC T
Il1b R ATC TTT TGG GGT CCG TCA ACT
Il4 F TTT GAA CGA GGT CAC AGG AG
Il4 R TTC TTC GTT GCT GTG AGG AC
Il6 F TAG TCC TTC CTA CCC CAA TTT CC
Il6 R TTG GTC CTT AGC CAC TCC TTC
Il10 F GCT CTT ACT GAC TGG CAT GAG
Il10 R CGC AGC TCT AGG AGC ATG TG
Il12b F CCA GAG ACA TGG AGT CAT AG
Il12b R AGA TGT GAG TGG CTC AGA GT
Csf2 F CAG CTT CTC AGA CTG CTG CT
Csf2 R CTT GGT CCC TTT AAG GCA GA
Tnfa F CCC TCA CAC TCA GAT CAT CTT CT
Tnfa R GCT ACG ACG TGG GCT ACA G
Nos2 F GTT CTC AGC CCA ACA ATA CAA GA
Nos2 R GTG GAC GGG TCG ATG TCA C
Gapdh F TGT GTC CGT CGT GGA TCT GA
Gapdh R CCT GCT TCA CCA CCT TCT TGA
doi:10.1371/journal.pone.0136699.t001
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however, incubation with SP-D did significantly decrease the viability of E. coli in agreement
with previous results (Fig 3a and 3b) [14].
SP-D causes a decrease in C. burnetii interactions with macrophages
SP-D interactions are known to modulate attachment and uptake of many Gram- negative bac-
teria by a variety of cell types [11,23,24]. To determine whether SP-D was able to modulate the
adherence and uptake of C. burnetii by MH-S cells, a murine alveolar macrophage cell line, the
amount of adherent and internalize C. burnetii was determined using fluorescently labeled bac-
teria [18]. We used both C. burnetii grown in axenic ACCM-2 media and C. burnetii grown in
L-929 cells to determine if growth in axenic media alters the physiological properties of the
bacterium. As shown in Fig 4, SP-D treatment significantly reduced the C. burnetii infectivity
index (bound and internalized C. burnetii) at 8 hrs of infection for both ACCM-2 and L-929
grown bacteria. Interestingly, we observed that SP-D was able to modulate interactions of L-
929 grown C. burnetii at 4 hrs, but had no effect at this time for ACCM-2 grown C. burnetii
(Fig 4). This suggests that the passage history (media vs cell line infection) of the C. burnetii
may affect binding interactions with cells via surface receptor that interact with the ligand
SP-D.
Fig 1. SP-D binds toC. burnetii in a calcium dependent fashion that can be inhibited by monosaccride. SP-D was incubated withC. burnetii or E. coli
with or without EDTA or galactose, in PBS + CaCl2 overnight at 37°C. Bacterial suspensions were then washed 3x with PBS by centrifugation. All samples
were subjected to SDS-PAGE followed by blotting to detect SP-D that co-sedimented with the bacteria. SP-D was loaded as a positive control (left lane each
blot labeled SP-D). Representative results are shown from 3 independent experiments.
doi:10.1371/journal.pone.0136699.g001
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SP-D treatment does not result in modulation of macrophage activation
Our goals were two-fold in the comparison of C. burnetii infection of this alveolar macrophage
line. First we wanted to determine if MH-S cells mimic the activation observed by human alve-
olar macrophages due to C. burnetii infection to assess their usefulness as model cell line and
then to determine if SP-D alters this activation [7]. MH-S cells have been used as an in vitro
model for Legionella pneumophila infection the most closely related bacterial species to C. bur-
netii as an alternative to hard to obtain primary alveolar macrophages [25,26]. Therefore, we
determined the transcriptional responses of MH-S cells to both virulent phase I and avirulent
phase II C. burnetii. The following genes were selected to evaluate macrophage activation: Il1b,
Il4, Il6, Il10, Il12b, Cfs2, Nos2 and Tnfa. E. coli lipopolysaccharide (LPS) was used as a positive
control for macrophage activation. As shown in Fig 5, MH-S infected with either phase I or
phase II C. burnetii resulted in a significant induction of Il1b, Il6, Il12b, Csf2, Nos2 and Tnfa
Fig 2. SP-D does not cause aggregation ofC. burnetii. (A) E. coli or (B) C. burnetiiwere incubated with or
without SP-D in PBS + CaCl2 in an undisturbed suspension for 3 or 4 hrs, respectively. The ability of SP-D to
aggregate the bacteria was determined using spectrometry readings at OD600. The data are representative of
3 independent experiments ± standard deviation. Student t-tests compare data sets +/- SP-D ** p<0.005,
*** p<0.0005.
doi:10.1371/journal.pone.0136699.g002
SP-D BindsC. burnetii and Decreases Host Cell Interactions
PLOS ONE | DOI:10.1371/journal.pone.0136699 September 14, 2015 6 / 12
when compared to uninfected control. Infection with C. burnetii did not induce significant
production of Il4 or Il10 (Fig 5). Although infection with C. burnetii increase the expression of
Nos2 there was no production of nitrites by these cells, which agrees with previous results using
human (Fig 6) [27]. Pre-incubation of phase II C. burnetii with SP-D prior to infection did not
affect the transcriptional response of MH-S cells (Fig 6).
Discussion
Our data demonstrate that C. burnetii interacts with SP-D in a calcium-dependent manner
that can be inhibited by carbohydrate. SP-D has been previously shown to bind to the LPS of
many diverse pathogenic Gram-negative bacteria such as Pseudomonas aeruginosa, uropatho-
genic E. coli, Klebsiella pneumoniae and Helicobacter pylori in a calcium-dependent manner
that can be inhibited by carbohydrate [11,19,28,29]. Furthermore, it was determined C. burnetii
interactions with SP-D did not cause bacterial agglutination or bactericidal effects. Most bacte-
rial pathogens that bind SP-D are also agglutinated by SP-D including Streptococcus pneumo-
niae,Mycobacterium tuberculosis,H. pylori and approximately 50% of clinical Pseudomonas
aeruginosa isolates [12,13,30,31]. However, other examples of SP-D binding without
Fig 3. SP-D is not bactericidal towardsC. burnetii. (A) E. coli were treated with or without SP-D for one
hour at 37°C followed by viable counts on LB. Data displayed are mean ± standard error of three independent
experiments. Student t-test compares SP-D to PBS treated E. coli. * p<0.05. (B) C. burnetiiwere treated with
0 (triangles), 5 (squares) or 10 mg/ml (squares) SP-D overnight and transferred to ACCM-2. Every 2 days
genome equivalents (GE) were calculated by real-time PCR. Data displayed are mean ± standard deviation
of GE/mL, representative of three independent experiments.
doi:10.1371/journal.pone.0136699.g003
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aggregation exist, such as with Chlamydia trachomatis [32]. Thus the interactions of C. burentii
with SP-D do not result in aggregation similar to C. trachomatis. Bactericidal effects of SP-D
have only been demonstrated for E. coli or rough LPS variants of other bacteria such as Borde-
tella pertussis [14,33]. Therefore, it is somewhat surprising that phase II C. burnetii, which is a
rough variant is resistant to the bactericidal effects of SP-D.
Interactions with SP-D can also modulate adherence and phagocytosis; therefore, we inves-
tigated the effects of SP-D on C. burnetii interactions with MH-S cells. We observed that SP-D
decreases the infectivity of C. burnetii to MH-S cells (bound and internalized bacteria). It is
most likely that a decrease in adherence is responsible for this phenotype, but since this study
did not distinguish between bound and internalized C. burnetii that remains to be determined.
These interactions most closely resemble those observed forM. tuberculosis where SP-D
decreases adherence and therefore phagocytosis [30]. Other outcomes of SP-D interaction
include increased adherence to macrophages but decreases phagocytosis as for Pneumocystis
carinii or increased phagocytosis as seen with C. trachomatis [24,32]. Alternatively, SP-D can
cause increased uptake and killing of P. aerugionsa and K. pneumoniae [11,34].
Our data also indicate that C. burnetii infection drives MH-S alveolar macrophages towards
classical activation and the resulting transcriptional patterns are not altered with SP-D treat-
ment. Several other studies have evaluated the effects of SP-D on bacterial activation in macro-
phages. SP-D has no effect on the secretion of TNFα induced by P. aeruginosa [35]. On the
other hand, SP-D coated K. pneumophila cause an increase in expression of IL-6, IL-10, and
IL-12 [36]. LPS induces classical macrophage activation that results in resistance to intracellu-
lar pathogens and is characterized by secretion of IL-1β, TNF, IL-12, and IL-6 [27]. The activa-
tion patterns between C. burnetii and E. coli LPS were similar, although the magnitude of
induction was different hence the conclusion of classic activation. Interestingly, we observed a
greater induction of cytokine expression for phase I C. burnetii versus phase II C. burnetii at
very early time points (4 and 8 hrs) after infection. This is in contrast to the cytokine release
Fig 4. SP-D treatment results in a decrease in infectivity. ACCM-2 or L-929 passagedC. burnetiiwere
stained with CSFE and treated overnight with SP-D or the equivalent volume of buffer alone (PBS). MH-S
cells were infected at MOI 100 for 4 or 8 hours and fixed. MH-S nuclei were stained with Hoescht, the number
of infected cells and bacteria was quantified via confocal microscopy, and the infectivity index was calculated
(bound and internalized C. burnetii). Data are displayed as mean ± standard deviation of infectivity from one
representative of 5 experiments, n = 3. Student t-tests compare SP-D to PBS treated groups. *, p<0.05, ***,
p<0.0005.
doi:10.1371/journal.pone.0136699.g004
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profiles observed after 24 hours of infection in human derived alveolar macrophages, where
phase II causes the largest release of cytokines [7]. These differences may be due to the time
points observed or due to analyzing expression profiles over cytokine release. The expression
profiles after infection of L. pneumophila in MH-S cells and human derived alveolar macro-
phages were found to be similar [26]. We therefore conclude that MH-S cells represent a viable
model for studying C. burnetii alveolar macrophage interactions.
In conclusion, SP-D binding to C. burnetii is calcium-dependent and can be inhibited by
carbohydrate. SP-D decreases the interactions of C. burnetii to MH-S cells, these interactions
are most similar toM. tuberculosis. Future experiments will help define the role of SP-D in the
innate response to C. burnetii. For example, it will be important to determine if SP-D coated C.
burnetii are viable once phagocytosed or if coated of SP-D causes intracellular killing as it does
for the closely related L. pneumophila [37].
Fig 5. SP-D treatment does not alterC. burnetii stimulated transcriptional patterns in MH-S cells.MH-S cells were infected with PBS or SP-D treated
C. burnetiiRSA439 (phase II), RSA493 (phase I) or treated with E. coli LPS for 0, 4, and 8 hours. RNA was extracted as described and applied to real-time
PCR. Data represent the mean ± standard deviation of fold change in RNA expression of select genes compared to expression of host cellGapdh, n = 3.
RSA439 and LPS data are representative of three independent experiments, RSA493 data are representative of two independent experiments. Student t-
tests compare each time and condition to its corresponding 0 time point, all RSA439 and RSA439 + SP-D were significantly up-regulated * p<0.05. There
was no significant difference in expression between untreated and SP-D treatedC. burnetiiRSA439 as determined by student t-tests.
doi:10.1371/journal.pone.0136699.g005
SP-D BindsC. burnetii and Decreases Host Cell Interactions
PLOS ONE | DOI:10.1371/journal.pone.0136699 September 14, 2015 9 / 12
Acknowledgments
We would like to thanks Laura Hendrix and Robert Faris for helpful discussions. We would
also like to thank Liz Case for critical review of this manuscript.
Author Contributions
Conceived and designed the experiments: KS EVS JS. Performed the experiments: KS. Ana-
lyzed the data: KS EVS. Contributed reagents/materials/analysis tools: KS JS. Wrote the paper:
KS EVS.
References
1. van Schaik EJ, Chen C, Mertens K, Weber MM, Samuel JE (2013) Molecular pathogenesis of the obli-
gate intracellular bacteriumCoxiella burnetii. Nat Rev Micro advance online publication.
2. Maurin M, Raoult D (1999) Q Fever. Clinical Microbiology Reviews 12: 518–553. PMID: 10515901
3. Moos A, Hackstadt T (1987) Comparative virulence of intra- and interstrain lipopolysaccharide variants
of Coxiella burnetii in the guinea pig model. Infection and Immunity 55: 1144–1150. PMID: 3570458
4. Narasaki C, Toman R (2012) Lipopolysaccharide ofCoxiella burnetii. In: Toman R, Heinzen RA, Sam-
uel JE, Mege J-L, editors.Coxiella burnetii: Recent Advances and New Perspectives in Research of
the Q Fever Bacterium: Springer Netherlands. pp. 65–90.
5. Howe D, Shannon JG, Winfree S, Dorward DW, Heinzen RA (2010)Coxiella burnetii Phase I and II Var-
iants Replicate with Similar Kinetics in Degradative Phagolysosome-Like Compartments of Human
Macrophages. Infection and Immunity 78: 3465–3474. doi: 10.1128/IAI.00406-10 PMID: 20515926
6. WuHM, Jin M, Marsh CB (2005) Toward functional proteomics of alveolar macrophages. American
Journal of Physiology—Lung Cellular and Molecular Physiology 288: L585–L595. PMID: 15757951
7. Graham JG, MacDonald LJ, Hussain SK, Sharma UM, Kurten RC, Voth DE (2013) Virulent Coxiella
burnetii pathotypes productively infect primary human alveolar macrophages. Cellular Microbiology
15: 1012–1025. doi: 10.1111/cmi.12096 PMID: 23279051
8. Sano H, Kuroki Y (2005) The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity.
Molecular Immunology 42: 279–287. PMID: 15589315
9. Sano H, Kuronuma K, Kudo K, Mitsuzawa H, Sato M, Murakami S, et al. (2006) Regulation of inflamma-
tion and bacterial clearance by lung collectins. Respirology 11: S46–S50. PMID: 16423271
Fig 6. SP-D treatment does not alter C. burnetii stimulated nitric oxide secretion.MH-S cells were
infected with PBS or SP-D treatedC. burnetii (Cb or Cb + SP-D respectively) or E. coli LPS (LPS) for 8, 12,
and 24 hours at which point cell supernatants were removed and evaluated for nitrate production via the
Greiss assay. The data represent the mean ± standard deviation of NOmM in cell culture supernatant n = 3
and are compared to uninfected and untreated controls using student t-tests ** p<0.005, *** p<0.0005.
doi:10.1371/journal.pone.0136699.g006
SP-D BindsC. burnetii and Decreases Host Cell Interactions
PLOS ONE | DOI:10.1371/journal.pone.0136699 September 14, 2015 10 / 12
10. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, et al. (2006) Surfactant proteins
SP-A and SP-D: Structure, function and receptors. Molecular Immunology 43: 1293–1315. PMID:
16213021
11. Restrepo CI, Dong Q, Savov J, MariencheckWI, Wright JR (1999) Surfactant Protein D Stimulates
Phagocytosis of Pseudomonas aeruginosa by Alveolar Macrophages. American Journal of Respiratory
Cell and Molecular Biology 21: 576–585. PMID: 10536117
12. Griese M, Starosta V (2005) Agglutination of Pseudomonas aeruginosa by Surfactant Protein D. Pedi-
atric Pulmonology 40: 378–384. PMID: 16130114
13. Jounblat R, Kadioglu A, Iannelli F, Pozzi G, Eggleton P, Andrew PW (2004) Binding and Agglutination
of Streptococcus pneumoniae by Human Surfactant Protein D (SP-D) Vary between Strains, but SP-D
Fails To Enhance Killing by Neutrophils. Infection and Immunity 72: 709–716. PMID: 14742512
14. WuH, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, et al. (2003) Surfactant proteins A and D
inhibit the growth of Gram-negative bacteria by increasing membrane permeability. The Journal of Clini-
cal Investigation 111: 1589–1602. PMID: 12750409
15. Ferguson JS, Voelker DR, Ufnar JA, Dawson AJ, Schlesinger LS (2002) Surfactant Protein D Inhibition
of Human Macrophage Uptake ofMycobacterium tuberculosis Is Independent of Bacterial Agglutina-
tion. The Journal of Immunology 168: 1309–1314. PMID: 11801670
16. Samuel JE, Hendrix LR (2009) Laboratory Maintenance ofCoxiella burnetii. Current Protocols in Micro-
biology: JohnWiley & Sons, Inc.
17. Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, Hansen B, et al. (2011) Isolation from Animal Tis-
sue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth
Medium. Applied and Environmental Microbiology 77: 3720–3725. doi: 10.1128/AEM.02826-10 PMID:
21478315
18. Mbawuike IN, Herscowitz HB (1989) MH-S, a murine alveolar macrophage cell line: morphological,
cytochemical, and functional characteristics. Journal of Leukocyte Biology 46: 119–127. PMID:
2787372
19. Kurimura Y, Nishitani C, Ariki S, Saito A, Hasegawa Y, Takahashi M, et al. (2012) Surfactant Protein D
Inhibits Adherence of Uropathogenic Escherichia coli to the Bladder Epithelial Cells and the Bacterium-
induced Cytotoxicity: A POSSIBLE FUNCTION IN URINARY TRACT. Journal of Biological Chemistry
287: 39578–39588. doi: 10.1074/jbc.M112.380287 PMID: 23012359
20. Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantita-
tive PCR and the 2−ΔΔCTMethod. Methods 25: 402–408. PMID: 11846609
21. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. (2009) The MIQE Guidelines:
Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry
55: 611–622. doi: 10.1373/clinchem.2008.112797 PMID: 19246619
22. Persson A, Chang D, Crouch E (1990) Surfactant protein D is a divalent cation-dependent carbohy-
drate-binding protein. Journal of Biological Chemistry 265: 5755–5760. PMID: 2108147
23. Hogenkamp A, Herías MV, Tooten PCJ, Veldhuizen EJA, Haagsman HP (2007) Effects of surfactant
protein D on growth, adhesion and epithelial invasion of intestinal Gram-negative bacteria. Molecular
Immunology 44: 3517–3527. PMID: 17477970
24. O'Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH (1995) Surfactant protein D
interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. The
Journal of Clinical Investigation 95: 2699–2710. PMID: 7769109
25. Yan L, Cirillo JD (2004) Infection of murine macrophage cell lines by Legionella pneumophila. FEMS
Microbiology Letters 230: 147–152. PMID: 14734178
26. Matsunaga K, Klein TW, Friedman H, Yamamoto Y (2001) Alveolar Macrophage Cell Line MH-S Is
Valuable as an In Vitro Model for Legionella pneumophila Infection. American Journal of Respiratory
Cell and Molecular Biology 24: 326–331. PMID: 11245632
27. Benoit M, Barbarat B, Bernard A, Olive D, Mege JL (2008) Coxiella burnetii, the agent of Q fever, stimu-
lates an atypical M2 activation program in humanmacrophages. European Journal of Immunology 38:
1065–1070. doi: 10.1002/eji.200738067 PMID: 18350541
28. Yokota S, Amano K, Nishitani C, Ariki S, Kuroki Y, Fujii N (2012) Implication of Antigenic Conversion of
Helicobacter pylori Lipopolysaccharides That Involve Interaction with Surfactant Protein D. Infection
and Immunity 80: 2956–2962. doi: 10.1128/IAI.00345-12 PMID: 22615243
29. Lim BL, Wang JY, Holmskov U, Hoppe HJ, Reid KBM (1994) Expression of the Carbohydrate Recogni-
tion Domain of Lung Surfactant Protein D and Demonstration of Its Binding to Lipopolysaccharides of
Gram-Negative Bacteria. Biochemical and Biophysical Research Communications 202: 1674–1680.
PMID: 8060356
SP-D BindsC. burnetii and Decreases Host Cell Interactions
PLOS ONE | DOI:10.1371/journal.pone.0136699 September 14, 2015 11 / 12
30. Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS (1999) Surfactant Protein D Binds toMyco-
bacterium tuberculosis Bacilli and Lipoarabinomannan via Carbohydrate-Lectin Interactions Resulting
in Reduced Phagocytosis of the Bacteria by Macrophages1. The Journal of Immunology 163: 312–
321. PMID: 10384130
31. Khamri W, Moran AP, Worku ML, Karim QN, Walker MM, Annuk H, et al. (2005) Variations in Helico-
bacter pylori Lipopolysaccharide To Evade the Innate Immune Component Surfactant Protein D. Infec-
tion and Immunity 73: 7677–7686. PMID: 16239572
32. Oberley RE, Ault KA, Neff TL, Khubchandani KR, Crouch EC, Snyder JM (2004) Surfactant proteins A
and D enhance the phagocytosis of Chlamydia into THP-1 cells. Lung Cellular and Molecular Physiol-
ogy 287: 296–306.
33. Schaeffer LM, McCormack FX, Wu H, Weiss AA (2004) Interactions of Pulmonary Collectins with Bor-
detella bronchiseptica and Bordetella pertussis Lipopolysaccharide Elucidate the Structural Basis of
Their Antimicrobial Activities. Infection and Immunity 72: 7124–7130. PMID: 15557636
34. Ofek I, Mesika A, Kalina M, Keisari Y, Podschun R, Sahly H, et al. (2001) Surfactant Protein D
Enhances Phagocytosis and Killing of Unencapsulated Phase Variants of Klebsiella pneumoniae.
Infection and Immunity 69: 24–33. PMID: 11119485
35. Bufler P, Schmidt B, Schikor D, Bauernfeind A, Crouch EC, Griese H (2003) Surfactant Protein A and D
Differently Regulate the Immune Response to Nonmucoid Pseudomonas aeruginosa and Its Lipopoly-
saccharide. American Journal of Respiratory Cell and Molecular Biology 28: 249–256. PMID:
12540493
36. Keisari Y, Wang H, Mesika A, Matatov R, Nissimov L, Crouch E, et al. (2001) Surfactant protein D-
coated Klebsiella pneumoniae stimulates cytokine production in mononuclear phagocytes. Journal of
Leukocyte Biology 70: 135–141. PMID: 11435496
37. Sawada K, Ariki S, Kojima T, Saito A, Yamazoe M, Nishitani C, et al. (2010) Pulmonary Collectins Pro-
tect Macrophages against Pore-forming Activity of Legionella pneumophila and Suppress Its Intracellu-
lar Growth. Journal of Biological Chemistry 285: 8434–8443. doi: 10.1074/jbc.M109.074765 PMID:
20056602
SP-D BindsC. burnetii and Decreases Host Cell Interactions
PLOS ONE | DOI:10.1371/journal.pone.0136699 September 14, 2015 12 / 12
